arrow
S

Sebastian Brandner

university college london hospitals nhs foundation trust
H指数:17
被引数:958

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neuropath-IHC: a deep neural network for virtual immunohistochemistry from digital whole slide images of CNS tumors

神经病理-IHC:一种用于中枢神经系统肿瘤数字全切片图像虚拟免疫组化分析的深度神经网络

2025-11-010
OAAI
Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genes

分子特征将BAP1-altered脑膜瘤定义为一种具有Polycomb抑制复合物靶基因失调的特定中枢神经系统肿瘤

2025-06-014
PRE
ROBIN: A unified nanopore-based assay integrating intraoperative methylome classification and next-day comprehensive profiling for ultra-rapid tumor diagnosis

ROBIN:一种统一的基于纳米孔的检测方法,整合了术中甲基组分类和次日全面分析,用于超快速肿瘤诊断

2025-05-200
OA
Molecular, histologic, and clinical characterization of methylation class pleomorphic xanthoastrocytoma: An analysis of 469 tumors

甲基化类别多形性黄色星形细胞瘤的分子、组织学和临床特征:一项469例肿瘤的分析

2025-01-010
PRE
Defining benchmark outcomes for mesial temporal lobe epilepsy surgery: A global multicenter analysis of 1119 cases

确定内侧颞叶癫痫手术的基准结果: 1119例全球多中心分析

2024-02-244
OAAI
Deep histopathology genotype-phenotype analysis of focal cortical dysplasia type II differentiates between the GATOR1-altered autophagocytic subtype IIa and MTOR-altered migration deficient subtype IIb

II型局灶性皮质发育不良的深层组织病理学基因型-表型分析GATOR1-altered自噬细胞亚型IIa和MTOR改变的迁移缺陷亚型IIb之间的差异

2023-11-093
OA
Tracking cell turnover in human brain using 15N-thymidine imaging mass spectrometry
2023-09-281
OAAI
Age of epilepsy onset as modulating factor for naming deficit after epilepsy surgery: a voxel-based lesion-symptom mapping study
2023-09-012
OAAI
Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes (vol 145, pg 815, 2023)
2023-04-280
OA
Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes
2023-03-278
OA